Taking it to the street
Results 1 - 10 of 317 : 1 2 3 4 5 6 7 8 9 Next
Get RSS Feed for Life Sciences Tools and Services
$1,000 genetic sequencing bodes well for this stock.
This Takeover Is Off the Table. Maybe.
Has Roche walked away from Illumina, or is it bluffing?
It's Time to Start Buying Into the Next Bubble
This revolutionary technology will change the world... and your portfolio.
You, Sir, Are No Apple (but We Still Want to Buy You)
Roche insults Illumina, Lloyd Bentsen-style.
2 Stocks That Just Raised the Bar
A bullish market signal and positive CAPS sentiment might make a winning combination.
Is this meaningful? Or just another movement?
Complete Genomics can process saliva samples now.
Roche ups its offer for Illumina; investors want more.
Is Wall Street Wrong About These Stocks?
You love 'em, analysts are meh -- who's got it right?
Calling This Buyout Offer Bluff
Roche won't take no for an answer.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK